1. Home
  2. MTRX vs TENX Comparison

MTRX vs TENX Comparison

Compare MTRX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$11.33

Market Cap

361.0M

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$15.02

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
TENX
Founded
1984
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.0M
317.8M
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
MTRX
TENX
Price
$11.33
$15.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$17.00
$29.67
AVG Volume (30 Days)
175.1K
1.4M
Earning Date
05-06-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$769,286,000.00
N/A
Revenue This Year
$19.75
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.64
N/A
52 Week Low
$9.88
$5.80
52 Week High
$15.97
$19.40

Technical Indicators

Market Signals
Indicator
MTRX
TENX
Relative Strength Index (RSI) 30.67 49.50
Support Level $10.71 $13.13
Resistance Level $12.62 $16.35
Average True Range (ATR) 0.49 1.20
MACD -0.10 -0.22
Stochastic Oscillator 4.38 19.03

Price Performance

Historical Comparison
MTRX
TENX

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: